Drug Repositioning Bringing New Life to Shelved Assets and Existing Drugs

by Barratt, Michael J.; Frail, Donald E.

• ISBN13: 9780470878279
• ISBN10: 0470878274
• Edition: 1st
• Format: Hardcover
• Copyright: 2012-05-29
• Publisher: Wiley

Summary

With Viagra the most famous example, drug repositioning has been growing in importance for pharmaceutical companies seeking to reinvigorate development pipelines. This book provides a broad overview of drug repositioning including the business reasons and unique opportunities and challenges. Its coverage also presents a number of current and emerging technologies that are being applied, along with relevant case studies, as well as neglected diseases to consider. Pharmaceutical researchers will learn how to use drug repositioning techniques to increase the lifespan and applications of their drugs, and also decrease both costs and development time.

Author Biography

Michael Barratt is an independent consultant and previously?Senior Director and Technology Platform Leader at Pfizer's Global Indications Discovery Research Unit. He has?over 15?years of experience in preclinical drug discovery research and leadership.

Donald Frail is an independent consultant and previously?Vice President of Pfizer Global Research and Development and Head of Pfizer's Global Indications Discovery Research Unit. He has over 20 years of industrial research and management experience in preclinical drug discovery and early clinical research.

Table of Contents

Introduction

Drug Repositioning: Business Case, Strategies and Operational Considerations

Drug Repositioning: The Business Case and Current Strategies to Repurpose Shelved Candidates and Marketed

Opportunities and challenges associated with developing additional indications for clinical development candidates and marketed drugs

Clinical and operational considerations in repositioning marketed drugs and drug candidates

Regulatory considerations and strategies for drug repositioning

Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs

Computational and Bioinformatic Strategies for Drug Repositioning

Mining scientific and clinical databases to identify novel uses for existing drugs

Predicting the polypharmacology of drugs: Identifying new uses through chemoinformatics, structural informatics and molecular modeling based approaches

Systemic phenotypic screening for novel synergistic combinations: A new paradigm for repositioning existing drugs

Phenotypic in vivo screening to identify new, unpredicted indications for existing drugs and drug candidates

Old Drugs Yield New Discoveries: Examples from the Prodrug, Chiral Switch and Site-Selective Deuteration Strategies

Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry

Repurposing Drugs for Tropical Diseases: Case Studies and Open-source Screening Initiatives

Drug Repositioning Efforts by Non-Profit Foundations

Repositioning Drugs for Leukemia and Lymphoma: Perspective From The Leukemia & Lymphoma Society

Repositioning drugs for Parkinson's disease: Perspective from the Michael J. Fox Foundation

Repositioning drugs for Polycystic Kidney Disease (PKD): Perspectives from the Polycystic Kidney Disease Foundation

Business Development Strategies in the Repositioning Industry

A Case Study in Drug Repositioning: Sosei

Table of Contents provided by Publisher. All Rights Reserved.